Natus Medical

Health Manufacturing & Industrial healthtech medical devices medical diagnostics surgical solutions

Natus Medical is a leading manufacturer of medical devices and software and a service provider for the Newborn Care, Neurology, Sleep, Hearing and Balance markets. Natus products are used in hospitals, clinics and laboratories worldwide. The Company's mission is to improve outcomes and patient care in target markets through innovative screening, diagnostic and treatment solutions.

Revenue(Q1, 2017)

$124.7 M

Market capitalization(2017-08-22)

$1.1 B

Company Growth (employees)

Type

Public

Pleasanton, US

Founded

1989

Size (employees)

1,160 (est)

Website

natus.com

Natus Medical was founded in 1989 and is headquartered in Pleasanton, US

Natus Medical Office Locations

Natus Medical has offices in Pleasanton, Chicago, Louisville, Middleton and in 88 other locations

Pleasanton, US (HQ)

120 6701 Koll Center Pkwy

Show all (91)

Natus Medical Data and Metrics

Natus Medical Financial Metrics

Natus Medical's revenue was reported to be $124.7 m in Q1, 2017

Summary

USD

Natus Medical's current market capitalization is $1.1 b.

Income Statement

Annual

USD	FY, 2013	FY, 2014	FY, 2015	FY, 2016
Revenue	344.1 m	355.8 m	375.9 m	381.9 m
Revenue growth, %		3%	6%	2%
Cost of goods sold	142.1 m		145.5 m	144.6 m
Gross profit	202 m		230.4 m	237.3 m
Gross profit Margin, %	59%		61%	62%
R&D expense				33.4 m
General and administrative expense				50.9 m
Operating expense total				84.3 m
EBIT	34.3 m	45.9 m	53.5 m	55.3 m
EBIT margin, %	10%	13%	14%	14%
Net Income	22.9 m	32.5 m	37.9 m	42.6 m

Quarterly

USD	Q2, 2014	Q3, 2014	Q1, 2015	Q2, 2015	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017
Revenue	86.3 m	89.9 m	89.4 m	91.9 m	94.6 m	87.3 m	96 m	90.9 m	124.7 m
Cost of goods sold	35.3 m	34.3 m	35.1 m	33.8 m	35.5 m	32.5 m	37.9 m	32.2 m	56.9 m
Gross profit	51 m	55.5 m	54.3 m	58.1 m	59.1 m	54.9 m	58.1 m	58.7 m	67.7 m
Gross profit Margin, %	59%	62%	61%	63%	62%	63%	61%	65%	54%
R&D expense	7.9 m	8.2 m	6.9 m	7.3 m	7.7 m	7.8 m	7.1 m	7.7 m	12.8 m
General and administrative expense	10.8 m	14.7 m	11.6 m	11.7 m	10 m	12.5 m	11.9 m	12.8 m	16 m
Operating expense total	18.7 m	22.9 m	18.4 m	19 m	17.7 m	20.3 m	19 m	20.5 m	28.8 m
EBIT	10.3 m	12.8 m	13.3 m	14 m	16.1 m	11.2 m	13.9 m	15.2 m	1.4 m
EBIT margin, %	12%	14%	15%	15%	17%	13%	15%	17%	1%
Net Income	7.7 m	7.8 m	8.6 m	9.9 m	10.9 m	8.5 m	10.5 m	13.3 m	348 k

Balance Sheet

Annual

USD	FY, 2013	FY, 2014	FY, 2015	FY, 2016
Cash	56.1 m	66.6 m	82.5 m	213.6 m
Inventories	37.7 m	40.1 m	48.6 m	49.6 m
Current Assets	196.8 m	217.8 m	241.4 m	405.8 m
PP&E	23.3 m	17.9 m	17 m	17.3 m
Goodwill	97.2 m	96.3 m	107.5 m	113.1 m
Total Assets	426.4 m	434.8 m	479.5 m	649 m
Accounts Payable	29.8 m	21.4 m	23.7 m	18.7 m
Total Debt	38 m	38 m		140 m
Current Liabilities	80.1 m	69.1 m	77.1 m	79.9 m
Total Liabilities				231.6 m
Retained Earnings	34.5 m	68.9 m	106.8 m	149.4 m
Total Equity	306.3 m	352.7 m	390.7 m	417.4 m
Debt to Equity Ratio	0.1 x	0.1 x		0.3 x
Debt to Assets Ratio	0.1 x	0.1 x		0.2 x
Financial Leverage	1.4 x	1.2 x	1.2 x	1.6 x

Quarterly

USD	Q2, 2014	Q3, 2014	Q1, 2015	Q2, 2015	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017
Cash	56 m	57.8 m	67 m	73.2 m	82.2 m	81.3 m	96.3 m	81.1 m	103.8 m
Inventories	35.5 m	37.1 m	41.4 m	44.9 m	46.1 m	45.7 m	43.6 m	51.7 m	67.7 m
Current Assets	189.9 m	193.3 m	218.2 m	228.4 m	247.5 m	228.3 m	245.9 m	266 m	316.5 m
PP&E	21.1 m	19.3 m	18.2 m	18.4 m	18 m	17.6 m	17.2 m	18.1 m	20.9 m
Goodwill	100.9 m	97.1 m	109.3 m	108.5 m	108.4 m	112.9 m	110.9 m	111.9 m	185.8 m
Total Assets	419.7 m	415 m	443.7 m	453.9 m	469.9 m	472.7 m	486.1 m	510.7 m	688.9 m
Accounts Payable	25 m	26.5 m	22.3 m	19.3 m	24.2 m	19.4 m	18.8 m	17.1 m	26.1 m
Current Liabilities	70.2 m	69.4 m	71.4 m	66.4 m	73.6 m	67.8 m	77.4 m	89.2 m	85.5 m
Retained Earnings	48.5 m	56.3 m	77.5 m	87.3 m	98.3 m	115.4 m	125.9 m	139.2 m	149.8 m
Total Equity	330.4 m	331.8 m		373.8 m	380.8 m	392.4 m	396.2 m	409.4 m	420.4 m
Financial Leverage	1.3 x	1.3 x		1.2 x	1.2 x	1.2 x	1.2 x	1.2 x	1.6 x

Cash Flow

Annual

USD	FY, 2013	FY, 2014	FY, 2015	FY, 2016
Net Income	22.9 m	32.5 m	37.9 m	42.6 m
Depreciation and Amortization	12.8 m	11.8 m	16 m	16.9 m
Accounts Receivable	9.4 m	(2.4 m)	(15 m)	19.7 m
Inventories	(2.3 m)	(2 m)	(12 m)	(7.7 m)
Accounts Payable	(1.4 m)	(7.6 m)	3.3 m	(5 m)
Cash From Operating Activities	36.8 m	42.1 m	36.9 m	72.7 m
Purchases of PP&E	(1.8 m)	(4.2 m)	(4.1 m)	(3.2 m)
Cash From Investing Activities	(22.3 m)	(10.6 m)	(19.5 m)	(53.3 m)
Cash From Financing Activities	17.2 m	(20.9 m)	832 k	118.4 m
Interest Paid	1.3 m	434 k		41 k
Income Taxes Paid	12.9 m	5.7 m	10.2 m	16.3 m

Quarterly

USD	Q2, 2014	Q3, 2014	Q1, 2015	Q2, 2015	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017
Net Income	7.7 m	7.8 m	8.6 m	9.9 m	10.9 m	8.5 m	10.5 m	13.3 m	348 k
Inventories	35.5 m	37.1 m	41.4 m	44.9 m	46.1 m	45.7 m	43.6 m	51.7 m	67.7 m
Accounts Payable	25 m	26.5 m	22.3 m	19.3 m	24.2 m	19.4 m	18.8 m	17.1 m	26.1 m

Ratios

USD	Y, 2017
Revenue/Employee	107.5 k
Financial Leverage	1.6 x

Natus Medical Market Value History

Market Position of Natus Medical

Competitors

TriVascular Technologies

Natus Medical

Company Growth (employees)

Natus Medical Office Locations

Natus Medical Data and Metrics

Natus Medical Financial Metrics

Summary

Revenue (Q1, 2017)

Gross profit (Q1, 2017)

Gross profit margin (Q1, 2017), %

Net income (Q1, 2017)

EBIT (Q1, 2017)

Market capitalization (22-Aug-2017)

Cash (31-Mar-2017)

Income Statement

Revenue

Revenue growth, %

Cost of goods sold

Gross profit

Gross profit Margin, %

R&D expense

General and administrative expense

Operating expense total

EBIT

EBIT margin, %

Net Income

Revenue

Cost of goods sold

Gross profit

Gross profit Margin, %

R&D expense

General and administrative expense

Operating expense total

EBIT

EBIT margin, %

Net Income

Balance Sheet

Cash

Inventories

Current Assets

PP&E

Goodwill

Total Assets

Accounts Payable

Total Debt

Current Liabilities

Total Liabilities

Retained Earnings

Total Equity

Debt to Equity Ratio

Debt to Assets Ratio

Financial Leverage

Cash

Inventories

Current Assets

PP&E

Goodwill

Total Assets

Accounts Payable

Current Liabilities

Retained Earnings

Total Equity

Financial Leverage

Cash Flow

Net Income

Depreciation and Amortization

Accounts Receivable

Inventories

Accounts Payable

Cash From Operating Activities

Purchases of PP&E

Cash From Investing Activities

Cash From Financing Activities

Interest Paid

Income Taxes Paid

Net Income

Inventories

Accounts Payable

Ratios

Revenue/Employee

Financial Leverage